Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,132 Jan 1 – Oct 9, 2026
- Disclosed funding
- $200B 1765 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| WS WindBorne SystemsCompany profile Operates autonomous sensing balloons and AI models for weather forecasting infrastructure Operates autonomous sensing balloons and AI models for weather forecasting infrastructure | $37M | Series B | Climate tech | United States | Investors | |
| FI Foundational IndustriesCompany profile AI-native factories designed to automate production of critical industrial equipment in the United States. AI-native factories designed to automate production of critical industrial equipment in the United States. | $25M | Seed | Industrial tech | United States | Investors | |
| ML Mitti LabsCompany profile Uses satellite imagery and AI to cut water use and methane emissions in rice farming Uses satellite imagery and AI to cut water use and methane emissions in rice farming | $9.5M | Series A | Climate tech | United States | Investors | |
| S SkinBitCompany profile Provides full-body skin scanning technology for early skin cancer detection and screening Provides full-body skin scanning technology for early skin cancer detection and screening | $6M | Pre-SeedPre-seed | Healthtech | United States | Investors | |
| AR Avatar RoboticsCompany profile Combines humanoid robots and remote operators for warehouse and manufacturing labor Combines humanoid robots and remote operators for warehouse and manufacturing labor | $6.5M | Seed | Robotics | United States | Investors | |
| LT LifeMine TherapeuticsCompany profile Develops fungal genome-derived therapeutics for organ transplant rejection Develops fungal genome-derived therapeutics for organ transplant rejection | $263M | Series D+Series EUndisclosed | Biotech | United States | Investors | |
| YC Yellow CardCompany profile Provides stablecoin infrastructure enabling businesses to hold, move, and manage US dollars Provides stablecoin infrastructure enabling businesses to hold, move, and manage US dollars | $40M | StrategicUndisclosed | Fintech | United States | Investors | |
| VB Vedanta BiosciencesCompany profile Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection | $60M | Growth | Biotech | United States | Investors | |
| AS Aurelius SystemsCompany profile Develops AI-powered autonomous directed-energy systems to detect and neutralize drone threats Develops AI-powered autonomous directed-energy systems to detect and neutralize drone threats | $40M | Series A | Defense tech | United States | Investors | |
| CL CND Life SciencesCompany profile Develops biomarker-based diagnostic tests for neurodegenerative diseases Develops biomarker-based diagnostic tests for neurodegenerative diseases | Undisclosed | Growth | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
125rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Mona, American Supercritical
55rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.